Analysts Goldman Sachs initiated coverage of Mobia Medical (MOBI) with a buy rating and a target price of $31, indicating 130% upside
Goldman Sachs has initiated coverage of Mobia Medical with a buy rating and a price target of $31, indicating a potential 130% upside, highlighting the company's innovative approach in the stroke recovery market.